Author
Listed:
- Tae Geum Kim
(Center for Jeongup Industry-Academy-Institute Cooperation, Chonbuk National University, Jeollabuk-do, Republic of Korea)
- Bong Jo Kang
(Ocean and Fisheries Research Institute, Jeju special self-governing province, Republic of Korea)
- Sang Ik Park
(College of Veterinary Medicine, Chonnam National University, Gwangju, Republic of Korea)
- Tae Jung Kim
(College of Veterinary Medicine, Chonnam National University, Gwangju, Republic of Korea)
Abstract
The viral haemorrhagic septicaemia virus (VHSV) causes high mortality in many marine and freshwater fish species, resulting in heavy economic losses in fish farming. Previously, cholera toxin B subunit (CTB)-fused recombinant viral haemorrhagic septicaemia virus glycoproteins (rec-VHSV-GPs) have been successfully expressed in tobacco, Nicotiana benthamiana. Here, we evaluated the potential of rec-VHSV-GPs as an oral vaccine against a live viral challenge. After immunisation of mice and fish (olive flounder, Paralichthys olivaceous) with those antigenic proteins in a feed additive form, the antibody titres were increased statistically, especially in the primed groups (P < 0.0001) in both the mouse and fish. After the viral challenge under low water temperature culture conditions (below 18 °C), the immunised fish were protected successfully against the challenge, showing a significantly lower mortality rate (P < 0.05). This result suggests that this plant-based immunisation system could induce an effective immune response. It could be used as a candidate to develop an oral vaccine for fish.
Suggested Citation
Tae Geum Kim & Bong Jo Kang & Sang Ik Park & Tae Jung Kim, 2019.
"Development of an oral vaccine using recombinant viral haemorrhagic septicaemia virus glycoproteins produced in tobacco,"
Veterinární medicína, Czech Academy of Agricultural Sciences, vol. 64(10), pages 456-461.
Handle:
RePEc:caa:jnlvet:v:64:y:2019:i:10:id:26-2019-vetmed
DOI: 10.17221/26/2019-VETMED
Download full text from publisher
As the access to this document is restricted, you may want to
for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:caa:jnlvet:v:64:y:2019:i:10:id:26-2019-vetmed. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Ivo Andrle (email available below). General contact details of provider: https://www.cazv.cz/en/home/ .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.